- HDSA Research
- Grant Applications
Research News & Reports
- Raptor Pharmaceuticals Announces Phase 2/3 Clinical Trial Results with Cysteamine (RP103) in Huntington’s disease
- Results of Phase 2 HD prevention and biomarker study (PRECREST) using high-dose of creatine published
- NIH announces first funding opportunities for the BRAIN Initiative
- Teva Pharmaceutical Industries to Purchase Huntexil from Neurosearch
- Postcard from CHDI February 2011
- HD Insights Volume 3
- Auspex Pharmaceuticals Plans Phase III Clinical Trial for Chorea in HD Patients
- Research News Archive
- Roche and ISIS form HD Alliance
- FDA Selects HD for Patient-Focused Drug Development
- ASO treatment delivered to Alzheimer's patients in Phase I Study
- Prana Completes Phase 2 Huntington's Disease Trial with PBT2
- Omeros Phase I OMS824 Trial Results Positive
- Pharmacological Treatment of Chorea in HD Clinical Practice
- Research Webinar Series
- Clinical Trials
- HDBuzz Research News
- HD Gene Symposium: 20 Years
- Therapies in Pipeline
- Research Conferences
- Scientific Advisory Board
- Research Pipeline
- Stem Cells
- HD Insights
- HD Glossary
- Links to Other Research
- Reports Library
- Research Investors Reports
NIH announces first funding opportunities for the BRAIN Initiative!
HDSA is excited to share with you that the NIH has announced $40 million of new brain research funding opportunities.
From NIH: You will recall that back in April, President Obama launched the Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative to accelerate the development and application of innovative new technologies. These technologies will enable researchers to generate a detailed map of brain activity that integrates both spatial and temporal information about cells and circuits. To develop the scientific and technological agenda for this bold effort at NIH, the NIH Director established a working group of the Advisory Committee to the Director http://acd.od.nih.gov/brain.htm
This group has been asked to develop a plan by the summer of 2014. As a first step, the working group issued an interim report identifying high priority investments for FY 2014<http://www.nih.gov/science/brain/11252013-Interim-Report-ExecSumm.pdf> on September 16. These findings were subsequently endorsed by both the ACD and the NIH Director.
In response to this report, NIH has developed six funding announcements for a total of $40 million in FY14. Collectively, these opportunities focus on advancing our technological capabilities for understanding how circuits of interacting neurons function to create behavior, with the ultimate goal of improving our scientific foundation for the diagnosis and treatment of brain disorders.
To read more about the BRAIN Initiative and to access these announcements, please visit http://www.nih.gov/science/brain/.